Experienced in Hemoglobin SC Disease

Dr. Vince D. Cataldo

Hematology Oncology | Hematology | Oncology
1515 Holcombe Blvd, 
Houston, TX 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Hemoglobin SC Disease
1515 Holcombe Blvd, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vince Cataldo is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Cataldo is rated as an Experienced provider by MediFind in the treatment of Hemoglobin SC Disease. His top areas of expertise are Angiosarcoma, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration. Dr. Cataldo is currently accepting new patients.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in LA
Hospital Affiliations
Harris Health
Our Lady Of The Lake Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Primewell Health Services
  • HMO
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

MD Anderson
1515 Holcombe Blvd, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Cancer Moonshot Biobank Research Protocol
Cancer Moonshot Biobank Research Protocol
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Procedure, Other
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Crizanlizuamb
Study Phase: Phase 2
Passive Immunity Trial for Our Nation (PassItOn)
Passive Immunity Trial for Our Nation (PassItOn)
Enrollment Status: Completed
Publish Date: November 03, 2022
Intervention Type: Biological
Study Drug: Anti-COVID-19 Plasma
Study Phase: Phase 3
A Randomized, Multicenter, Double-blind, Placebo-controlled, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
A Randomized, Multicenter, Double-blind, Placebo-controlled, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: December 30, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

11 Total Publications

Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.
Journal: Chest
Published: January 17, 2022
Similar Doctors
Advanced in Hemoglobin SC Disease
Dr. Samip R. Master
Hematology Oncology | Hematology | Oncology
Advanced in Hemoglobin SC Disease
Dr. Samip R. Master
Hematology Oncology | Hematology | Oncology

Texas Oncology PA

501 W Medical Ctr Blvd, 
Webster, TX 
 (19.9 miles away)
281-332-7505
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Samip Master is a Hematologist Oncology specialist and a Hematologist in Webster, Texas. Dr. Master is rated as a Distinguished provider by MediFind in the treatment of Hemoglobin SC Disease. His top areas of expertise are Sickle Cell Disease, Anemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Master is currently accepting new patients.

Experienced in Hemoglobin SC Disease
Dr. Martha P. Mims
Hematology Oncology | Hematology | Oncology
Experienced in Hemoglobin SC Disease
Dr. Martha P. Mims
Hematology Oncology | Hematology | Oncology

Baylor College Of Medicine

6720 Bertner Ave, 
Houston, TX 
 (0.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Martha Mims is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Mims is rated as a Distinguished provider by MediFind in the treatment of Hemoglobin SC Disease. Her top areas of expertise are Hypereosinophilic Syndrome, Essential Thrombocythemia, Non-Hodgkin Lymphoma, and Clear Cell Sarcoma. Dr. Mims is currently accepting new patients.

Experienced in Hemoglobin SC Disease
Dr. Sanam Loghavi
Hematology | Oncology
Experienced in Hemoglobin SC Disease
Dr. Sanam Loghavi
Hematology | Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
 (0.6 miles away)
713-592-5433
Languages Spoken:
English
See accepted insurances

Sanam Loghavi is a Hematologist and an Oncologist in Houston, Texas. Dr. Loghavi is rated as an Elite provider by MediFind in the treatment of Hemoglobin SC Disease. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cataldo's expertise for a condition
ConditionClose
      View All 70 Advanced Conditions
      View All 176 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile